nodes	percent_of_prediction	percent_of_DWPC	metapath
Amcinonide—ANXA1—Spinal Cord Injury—SOX9—osteoarthritis	0.0944	0.0978	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—FRZB—osteoarthritis	0.0504	0.0522	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—COL2A1—osteoarthritis	0.05	0.0518	CbGpPWpGaD
Amcinonide—ANXA1—Prostaglandin Synthesis and Regulation—PTGS2—osteoarthritis	0.0451	0.0468	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—IHH—osteoarthritis	0.0293	0.0304	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—IL1A—osteoarthritis	0.0269	0.0279	CbGpPWpGaD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—LEP—osteoarthritis	0.0267	0.0276	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—LEP—osteoarthritis	0.022	0.0228	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—MMP1—osteoarthritis	0.0187	0.0194	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—BGLAP—osteoarthritis	0.0183	0.019	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—osteoarthritis	0.0176	0.0183	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—TIMP1—osteoarthritis	0.0176	0.0182	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—ESR1—osteoarthritis	0.0173	0.0179	CbGpPWpGaD
Amcinonide—Fluoxymesterone—ESR1—osteoarthritis	0.0168	0.478	CrCbGaD
Amcinonide—ANXA1—GPCR downstream signaling—MCF2L—osteoarthritis	0.0166	0.0172	CbGpPWpGaD
Amcinonide—NR3C1—Signaling events mediated by HDAC Class II—ESR1—osteoarthritis	0.0164	0.017	CbGpPWpGaD
Amcinonide—NR3C1—Nuclear Receptors—ESR1—osteoarthritis	0.0164	0.017	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—PTGS2—osteoarthritis	0.0151	0.0156	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—MCF2L—osteoarthritis	0.0151	0.0156	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—IHH—osteoarthritis	0.0151	0.0156	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—CXCL8—osteoarthritis	0.0146	0.0152	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	0.0143	0.0148	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—IL1B—osteoarthritis	0.014	0.0145	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—MMP9—osteoarthritis	0.0132	0.0137	CbGpPWpGaD
Amcinonide—NR3C1—Nuclear Receptor transcription pathway—ESR1—osteoarthritis	0.013	0.0135	CbGpPWpGaD
Amcinonide—NR3C1—Endoderm Differentiation—SMAD3—osteoarthritis	0.0127	0.0131	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	0.0124	0.0128	CbGpPWpGaD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—osteoarthritis	0.0123	0.0128	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—BMP2—osteoarthritis	0.012	0.0124	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SMAD3—osteoarthritis	0.011	0.0114	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—MMP1—osteoarthritis	0.0109	0.0113	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—TGFB1—osteoarthritis	0.0109	0.0113	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	0.0103	0.0106	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—TNF—osteoarthritis	0.0102	0.0106	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—ESR1—osteoarthritis	0.0101	0.0105	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—CXCL8—osteoarthritis	0.01	0.0104	CbGpPWpGaD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—osteoarthritis	0.00996	0.0103	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—MMP1—osteoarthritis	0.00962	0.00997	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL1RN—osteoarthritis	0.00945	0.0098	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—osteoarthritis	0.00898	0.0093	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MCF2L—osteoarthritis	0.0089	0.00922	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IHH—osteoarthritis	0.0089	0.00922	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—CXCL8—osteoarthritis	0.00843	0.00874	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—IL6—osteoarthritis	0.00822	0.00852	CbGpPWpGaD
Amcinonide—Triamcinolone—PTGS2—osteoarthritis	0.00796	0.227	CrCbGaD
Amcinonide—NR3C1—Adipogenesis—SMAD3—osteoarthritis	0.00754	0.00781	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	0.00742	0.00769	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—CXCL8—osteoarthritis	0.00702	0.00728	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	0.00693	0.00718	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL1A—osteoarthritis	0.0068	0.00705	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—CXCL8—osteoarthritis	0.00671	0.00695	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—COL9A2—osteoarthritis	0.00653	0.00677	CbGpPWpGaD
Amcinonide—Betamethasone—PTGS2—osteoarthritis	0.00652	0.186	CrCbGaD
Amcinonide—NR3C1—Adipogenesis—LEP—osteoarthritis	0.00644	0.00667	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—MMP9—osteoarthritis	0.00635	0.00658	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—COL9A1—osteoarthritis	0.00634	0.00657	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—osteoarthritis	0.00619	0.00641	CbGpPWpGaD
Amcinonide—NR3C1—Endoderm Differentiation—TGFB1—osteoarthritis	0.00536	0.00555	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—IGF1—osteoarthritis	0.00532	0.00552	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—TGFB1—osteoarthritis	0.00524	0.00543	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CXCL8—osteoarthritis	0.00511	0.00529	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—MMP3—osteoarthritis	0.0051	0.00528	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoarthritis	0.00509	0.00527	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—BMP2—osteoarthritis	0.00434	0.0045	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—IL6—osteoarthritis	0.00395	0.00409	CbGpPWpGaD
Amcinonide—Dexamethasone—PTGS2—osteoarthritis	0.00379	0.108	CrCbGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CXCL8—osteoarthritis	0.0037	0.00383	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL1B—osteoarthritis	0.00355	0.00368	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—osteoarthritis	0.00348	0.0036	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—TGFB1—osteoarthritis	0.00319	0.00331	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MMP3—osteoarthritis	0.00301	0.00312	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—TNF—osteoarthritis	0.00298	0.00309	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CXCL8—osteoarthritis	0.00289	0.00299	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—SMAD3—osteoarthritis	0.00275	0.00285	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SMAD3—osteoarthritis	0.00273	0.00282	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CXCL8—osteoarthritis	0.00262	0.00272	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—TNF—osteoarthritis	0.00258	0.00267	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—IL6—osteoarthritis	0.0024	0.00249	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—LEP—osteoarthritis	0.00233	0.00241	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—ESR1—osteoarthritis	0.00225	0.00233	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ESR1—osteoarthritis	0.00222	0.0023	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—FN1—osteoarthritis	0.0022	0.00228	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL6—osteoarthritis	0.00208	0.00215	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IGF1—osteoarthritis	0.00192	0.00199	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CXCL8—osteoarthritis	0.00155	0.0016	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—IL6—osteoarthritis	0.00147	0.00153	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MMP9—osteoarthritis	0.0014	0.00145	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—SMAD3—osteoarthritis	0.00132	0.00137	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TGFB1—osteoarthritis	0.00115	0.0012	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—ESR1—osteoarthritis	0.00108	0.00112	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IL6—osteoarthritis	0.00087	0.000901	CbGpPWpGaD
